Zimmer Partners’s Satsuma Pharmaceuticals STSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-100,000
Closed -$1.97M – 110
2019
Q4
$1.97M Hold
100,000
– – 0.03% 69
2019
Q3
$1.5M Buy
+100,000
New +$1.55M 0.02% 90

Other funds holding STSA

Zimmer Partners's STSA Position: Q1 2020 in Review

Zimmer Partners sold out of Satsuma Pharmaceuticals (STSA) in Q1 2020, closing a stake of 100,000 shares — an estimated $1.97M sold.

Zimmer Partners first reported a position in STSA in Q3 2019 and held it in 2 quarters. The position peaked at $1.97M in Q4 2019. 36 funds tracked by Wall St. Rank hold STSA as of Q1 2020.

  • Zimmer Partners reported no remaining Satsuma Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Zimmer Partners sold 100,000 Satsuma Pharmaceuticals shares in Q1 2020, an estimated $1.97M.
  • Zimmer Partners first reported a position in Satsuma Pharmaceuticals in Q3 2019 and held it in 2 quarters.
  • Zimmer Partners's Satsuma Pharmaceuticals position peaked at $1.97M in Q4 2019.
  • 36 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals as of Q1 2020.

Based on Zimmer Partners's 13F filing for Q1 2020, filed 15 May 2020.